Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 7.75

(-1.65%)

Total Debt Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 1.56 Billion CNY , up 11.07% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 948.83 Million CNY , down -36.13% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported annual total debt of 1.4 Billion CNY in 2022, down -12.79% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported annual total debt of 1.61 Billion CNY in 2021, down -1.88% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported quarterly total debt of 1.56 Billion CNY for 2023 Q4, up 13.29% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported quarterly total debt of 1.37 Billion CNY for 2023 Q2, down -1.96% from previous quarter.

Annual Total Debt Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Total Debt of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	1.56 Billion CNY	11.07%
2022	1.4 Billion CNY	-12.79%
2021	1.61 Billion CNY	-1.88%
2020	1.64 Billion CNY	9.11%
2019	1.5 Billion CNY	19.8%
2018	1.25 Billion CNY	140.36%
2017	522.9 Million CNY	24.1%
2016	421.36 Million CNY	44.97%
2015	290.65 Million CNY	-3.55%
2014	301.35 Million CNY	0.6%
2013	299.56 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	948.83 Million CNY	-36.13%
2023 Q4	1.56 Billion CNY	13.29%
2023 Q2	1.37 Billion CNY	-1.96%
2023 FY	1.56 Billion CNY	11.07%
2022 FY	1.4 Billion CNY	-12.79%
2022 Q4	1.4 Billion CNY	-3.11%
2022 Q2	1.45 Billion CNY	-9.99%
2021 FY	1.61 Billion CNY	-1.88%
2021 Q4	1.61 Billion CNY	6.17%
2021 Q2	1.51 Billion CNY	-7.59%
2020 Q2	1.4 Billion CNY	-6.81%
2020 FY	1.64 Billion CNY	9.11%
2020 Q4	1.64 Billion CNY	17.08%
2019 FY	1.5 Billion CNY	19.8%
2019 Q4	1.5 Billion CNY	15.3%
2019 Q2	1.3 Billion CNY	3.9%
2018 FY	1.25 Billion CNY	140.36%
2018 Q4	1.25 Billion CNY	0.18%
2018 Q2	1.25 Billion CNY	139.94%
2017 Q2	392.2 Million CNY	-6.92%
2017 FY	522.9 Million CNY	24.1%
2017 Q4	522.9 Million CNY	33.32%
2016 FY	421.36 Million CNY	44.97%
2016 Q2	269.15 Million CNY	-7.4%
2016 Q4	421.36 Million CNY	56.55%
2015 Q2	278.75 Million CNY	-7.5%
2015 Q4	290.65 Million CNY	4.27%
2015 FY	290.65 Million CNY	-3.55%
2014 FY	301.35 Million CNY	0.6%
2014 Q4	301.35 Million CNY	0.0%
2013 FY	299.56 Million CNY	0.0%

Peer Total Debt Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	Total Debt	Total Debt Difference
Wanjia Group Holdings Limited	15.6 Million HKD	-9909.355%
China Health Group Limited	5.65 Million HKD	-27512.014%
Tai United Holdings Limited	1.67 Billion HKD	6.8%